期刊文献+

系统性红斑狼疮患者脱发表现的初步观察 被引量:5

下载PDF
导出
摘要 脱发是系统性红斑狼疮(SLE)常见的临床表现之一,其发生率为17.3%~54%。脱发与疾病活动指数有关,是疾病加重的非特异性表现,还能预测SLE的复发闻。SLE脱发主要是非瘢痕性脱发,目前关于这方面的研究并不多,分类也不统一。本研究旨在分析SLE非瘢痕性脱发的临床及皮肤镜表现,探讨脱发与疾病活动性、自身抗体及补体水平之间的关系。
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2011年第9期548-549,共2页 Journal of Clinical Dermatology
  • 相关文献

参考文献10

  • 1Tang XH, Huang YM, Deng WM, et al. Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: a retrospective review of 917 patients in South China [J]. Medicine, 2010, 89(1): 62-67.
  • 2Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus [J]. Br J Dermatol, 1996, 135: 355-362.
  • 3Zeeevic RD, Vojvodic D, Ristic B, et al. Skin lesions-an indicator of disease activity in systemic lupus erythematosus?[J], Lupus, 2001, 10: 364-367.
  • 4Wysenbeek AJ, Leibovici L, Amit M, et al. Alopecia in systemic lupus erythematosus. Relation to disease manifestations [J]. J Rheumatol, 1991, 18(8): 1185-1186.
  • 5吴杰,李明.系统性红斑狼疮复发预测的初步研究[J].中华皮肤科杂志,2005,38(1):14-16. 被引量:6
  • 6Yun SJ, Lee JW, Yoon HJ, et al. Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopeeia [J]. J Dermatol, 2007, 34(7): 451-455.
  • 7RM Trueb. Involvement of scalp and nails in lupus erythematosus[J]. Lupus,2010, 19: 1078-1086.
  • 8Gladman DD, Urowitz MB, Kagal A, et ah Accurately descrihing changes in disease activity in Systemic Lupus Erythematosus [J]. J Rheumatol, 2000, 27(2): 377-379.
  • 9Olsen EA, Hordinsky M, Price VH, et al. Alopecia areata investigational assessment guidelines -Part II[J]. J Am Acad Dermatol,2004, 51(3): 440-447.
  • 10Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus[J]. J Am Acad Dermatol, 1981, 4(4): 471-475.

二级参考文献9

  • 1Petri M, Genovese M, Engle E, et al. Definition, incidence, and clinical description of flare in systemic' lupus erythematosus. A prospective cohort study. Arthritis Rheum, 1991, 34: 937-944.
  • 2ter Borg EJ, Horst G, Hummel EJ, et ah Measurement of increases in anti-double-stranded DNA antibody levels as a prcdietor of disease exacerbation in systemic lupus erythematosus. A long-term.prospective study. Arthritis Rheum, 1990. 33: 634-643.
  • 3Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.1982, 25: 1271-1277.
  • 4Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35: 630-640.
  • 5Livneh A, Or G, Many A, et al. Anti-DNA antibodies secreted by peripheral B cells of lupus patients have hoth normal and lupusspecific features. Clin Immunol Immunopathol. 1993.68: 68-73.
  • 6Miret C, Font J, Molina R, et al. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity. Anticancer Res, 1999, 19: 3073-3076.
  • 7Jodo S, Kobayashi S, Kayagaki N, el al. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases.Clin Exp Immunol, 1997, 107: 89-95.
  • 8Radic MZ, Mackle J, Erikson J, et al. Residues that mediate DNA binding of autoimmune antibodies. J Immunol. 1993, 150: 4966-4977.
  • 9Bootsma H, Spronk P, Derksen R, et al. Prevention of relapses in systemic lupus erythematosus. Lancet, 1995, 345: 1595-1599.

共引文献5

同被引文献62

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部